SELLAS Life Sciences (SLS) FCF Payout Ratio (2018)

SELLAS Life Sciences' (SLS) quarterly FCF Payout Ratio came in at 0.03 in Q3 2018.

SELLAS Life Sciences (SLS) FCF Payout Ratio (2018) Analysis & Trends

SELLAS Life Sciences (SLS) has 1 years of FCF Payout Ratio data on file, last reported at 0.03 in Q3 2018.

On a quarterly basis, FCF Payout Ratio changed N/A year-over-year to 0.03 in Q3 2018; TTM through Dec 2019 was 0.02, a 72.43% decrease from a year earlier, with the FY2018 full-year figure at 0.02, changed N/A from the prior year.
FCF Payout Ratio for Q3 2018 stood at 0.03.
Over the last five years, FCF Payout Ratio for SLS reached as high as 0.03 in Q3 2018 and fell as low as 0.03 in Q3 2018.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Cover (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	0.12
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	SELLAS Life Sciences	3.23 Mn	3.23 Mn	-	-

Historic Data

Download Data

Date	Value
Sep 30, 2018	-0.03